Photodynamic therapy (PDT) is an established treatment option for low-risk basal cell
carcinoma (BCC). BCC is the most common human cancer and also a convenient cancer in …

Photodynamic therapy (PDT) is currently enjoying considerable attention as the subject of
experimental research to treat resistant cancers. The preferential accumulation of a non …

The dense cancer microenvironment is a significant barrier that limits the penetration of
anticancer agents, thereby restraining the efficacy of molecular and nanoscale cancer …

Objective Cancer metabolic reprogramming promotes resistance to therapies. In this study,
we addressed the role of the Warburg effect in the resistance to photodynamic therapy (PDT) …

Background Basal cell carcinoma (BCC) represents about 80% of all cases of skin cancer.
The PTCH1 is a transmembrane protein of the Sonic Hedgehog signaling pathway that …

Abstract Cutaneous and Head and Neck squamous cell carcinoma (CSCC, HNSCC) are
among the most prevalent cancers. Both types of cancer can be treated with photodynamic …

Photodynamic therapy (PDT) has been used to treat certain types of non-melanoma skin
cancer with promising results. However, some skin lesions have not fully responded to this …

Photodynamic Therapy (PDT) with methyl-aminolevulinate (MAL-PDT) is being used for the
treatment of Basal Cell Carcinoma (BCC), although resistant cells may appear. Normal …

Squamous Cell Carcinoma (SCC) is a subtype of Non-Melanoma Skin Cancer, the most
common group of malignancies worldwide. Photodynamic therapy (PDT) is a non-invasive …

Photodynamic therapy (PDT) is a selective tumor treatment that consists of a photosensitive
compound—a photosensitizer (PS), oxygen, and visible light. Although each component has …